“Molnupiravir and Favipiravir in the Therapeutics of SARS-CoV-2 - A Review”. 2023. Indian Journal of Pharmacy & Drug Studies 1 (3): 73-78. https://mansapublishers.com/index.php/ijpds/article/view/3575.